27% growth in prescriptions dispensed over prior quarter; 147% growth over comparable quarter in 2022. 5 consecutive quarters of double-digit growth. Click here to learn more ›

The Melanocortin Pathway: A New Target For Ocular Disease Therapy

Scroll to Top